ProMIS Neurosciences at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

ProMIS Neurosciences at CTAD 2026 in Boston.

OrganizationCTAD 2026 Attendance
ProMIS Neurosciences
Toronto, Canada
◇Silver Sponsor
promisneurosciences.com
BiotechSilver Sponsor
Develops PMN310, an antibody designed to target only toxic amyloid-beta oligomers, in the phase 1b PRECISE-AD trial in early Alzheimer's.
Sponsor
In the meeting’s sponsor directory, with no session on the public program

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ProMIS Neurosciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction